tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Smith, 61 are a BUY (74.39%), 21 are a HOLD (25.61%).
Analyst Thomas Smith, carries an average stock price target met ratio of 43.63% that have a potential upside of 36.3% achieved within 118 days. Previously, Thomas Smith worked at LEERINK.
Thomas Smith’s has documented 152 price targets and ratings displayed on 28 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on QTTB, Q32 Bio at 11-Dec-2024.
Analyst best performing recommendations are on AXLA (AXCELLA HEALTH).
The best stock recommendation documented was for AXLA (AXCELLA HEALTH) at 12/15/2022. The price target of $6 was fulfilled within 1 day with a profit of $4.98 (45.36%) receiving and performance score of 453.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.79 (147.93%)
$3
10 months 10 days ago
(26-Sep-2024)
0/4 (0%)
$2.42 (417.24%)
Hold
$7
1 years 1 months 16 days ago
(20-Jun-2024)
1/3 (33.33%)
$0.45 (6.87%)
57
Sell
$1
$-0.21 (-17.36%)
$1.5
1 years 6 months 19 days ago
(17-Jan-2024)
6/6 (100%)
$-0.02 (-1.96%)
278
Buy
1 years 7 months 18 days ago
(18-Dec-2023)
1/1 (100%)
$32.69 (83.16%)
358
Buy
$9
$7.79 (643.80%)
2 years 2 months 25 days ago
(11-May-2023)
2/4 (50%)
$4.84 (116.35%)
178
What Year was the first public recommendation made by Thomas Smith?
